These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30343253)

  • 1. Assessing the burden of vascular risk factors on brain atrophy in multiple sclerosis: A case- control MRI study.
    Lorefice L; Frau J; Coghe G; Pitzalis R; Gessa I; Contu F; Barracciu MA; Marrosu MG; Cocco E; Fenu G
    Mult Scler Relat Disord; 2019 Jan; 27():74-78. PubMed ID: 30343253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune comorbidities in multiple sclerosis: what is the influence on brain volumes? A case-control MRI study.
    Lorefice L; Fenu G; Pitzalis R; Scalas G; Frau J; Coghe G; Musu L; Sechi V; Barracciu MA; Marrosu MG; Cocco E
    J Neurol; 2018 May; 265(5):1096-1101. PubMed ID: 29508133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of deep grey matter volume on cognition in multiple sclerosis.
    Lorefice L; Carta E; Frau J; Contu F; Casaglia E; Coghe G; Barracciu MA; Cocco E; Fenu G
    Mult Scler Relat Disord; 2020 Oct; 45():102351. PubMed ID: 32731200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bipolar disorders and deep grey matter in multiple sclerosis: A preliminary quantitative MRI study.
    Lorefice L; Fenu G; Carta E; Frau J; Coghe G; Contu F; Barracciu MA; Carta MG; Cocco E
    Mult Scler Relat Disord; 2020 Nov; 46():102564. PubMed ID: 33172832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy.
    Lorefice L; Fenu G; Sardu C; Frau J; Coghe G; Costa G; Schirru L; Secci MA; Sechi V; Barracciu MA; Marrosu MG; Cocco E
    Mult Scler; 2019 Jan; 25(1):23-30. PubMed ID: 29111883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal study.
    Jakimovski D; Gandhi S; Paunkoski I; Bergsland N; Hagemeier J; Ramasamy DP; Hojnacki D; Kolb C; Benedict RHB; Weinstock-Guttman B; Zivadinov R
    Eur J Neurol; 2019 Jan; 26(1):87-e8. PubMed ID: 30103277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Timed up and go' and brain atrophy: a preliminary MRI study to assess functional mobility performance in multiple sclerosis.
    Lorefice L; Coghe G; Fenu G; Porta M; Pilloni G; Frau J; Corona F; Sechi V; Barracciu MA; Marrosu MG; Pau M; Cocco E
    J Neurol; 2017 Nov; 264(11):2201-2204. PubMed ID: 28894919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study.
    Uher T; Krasensky J; Vaneckova M; Sobisek L; Seidl Z; Havrdova E; Bergsland N; Dwyer MG; Horakova D; Zivadinov R
    J Neuroimaging; 2017 Nov; 27(6):620-629. PubMed ID: 28464417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of Whole-Brain and Gray Matter Atrophy in Multiple Sclerosis: Assessment with MR Imaging.
    Storelli L; Rocca MA; Pagani E; Van Hecke W; Horsfield MA; De Stefano N; Rovira A; Sastre-Garriga J; Palace J; Sima D; Smeets D; Filippi M;
    Radiology; 2018 Aug; 288(2):554-564. PubMed ID: 29714673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
    Deppe M; Marinell J; Krämer J; Duning T; Ruck T; Simon OJ; Zipp F; Wiendl H; Meuth SG
    Neuroimage Clin; 2014; 6():475-87. PubMed ID: 25610761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis.
    Kappus N; Weinstock-Guttman B; Hagemeier J; Kennedy C; Melia R; Carl E; Ramasamy DP; Cherneva M; Durfee J; Bergsland N; Dwyer MG; Kolb C; Hojnacki D; Ramanathan M; Zivadinov R
    J Neurol Neurosurg Psychiatry; 2016 Feb; 87(2):181-7. PubMed ID: 25722366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
    Nocentini U; Bozzali M; Spanò B; Cercignani M; Serra L; Basile B; Mannu R; Caltagirone C; De Luca J
    Brain Imaging Behav; 2014 Sep; 8(3):378-86. PubMed ID: 22584774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between brain atrophy and cognitive motor interference in multiple sclerosis.
    Coghe G; Fenu G; Lorefice L; Zucca E; Porta M; Pilloni G; Corona F; Frau J; Giovanna Marrosu M; Pau M; Cocco E
    Mult Scler Relat Disord; 2018 Oct; 25():208-211. PubMed ID: 30103173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIENA-XL for improving the assessment of gray and white matter volume changes on brain MRI.
    Battaglini M; Jenkinson M; De Stefano N;
    Hum Brain Mapp; 2018 Mar; 39(3):1063-1077. PubMed ID: 29222814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain atrophy and lesion load in a large population of patients with multiple sclerosis.
    Tedeschi G; Lavorgna L; Russo P; Prinster A; Dinacci D; Savettieri G; Quattrone A; Livrea P; Messina C; Reggio A; Bresciamorra V; Orefice G; Paciello M; Brunetti A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Patti F; Salemi G; Cammarata E; Simone IL; Salvatore M; Bonavita V; Alfano B
    Neurology; 2005 Jul; 65(2):280-5. PubMed ID: 16043800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal associations between brain structural changes and fatigue in early MS.
    Nourbakhsh B; Azevedo C; Nunan-Saah J; Maghzi AH; Spain R; Pelletier D; Waubant E
    Mult Scler Relat Disord; 2016 Jan; 5():29-33. PubMed ID: 26856940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular disease risk factors in multiple sclerosis: Effect on metabolism and brain volumes.
    Sammi MK; Fryman A; Baker E; Moloney B; Powers K; West R; Bittner F; Lane M; Martin K; Pepelyayeva Y; Anderson VC; Rooney WD; Yadav V
    Mult Scler Relat Disord; 2023 Jun; 74():104675. PubMed ID: 37121104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semi-automatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS.
    Carone DA; Benedict RH; Dwyer MG; Cookfair DL; Srinivasaraghavan B; Tjoa CW; Zivadinov R
    Neuroimage; 2006 Jan; 29(2):505-14. PubMed ID: 16169253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What explains gray matter atrophy in long-standing multiple sclerosis?
    Steenwijk MD; Daams M; Pouwels PJ; Balk LJ; Tewarie PK; Killestein J; Uitdehaag BM; Geurts JJ; Barkhof F; Vrenken H
    Radiology; 2014 Sep; 272(3):832-42. PubMed ID: 24761837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-year study using cerebral gray matter volume to assess the response to fingolimod therapy in multiple sclerosis.
    Yousuf F; Dupuy SL; Tauhid S; Chu R; Kim G; Tummala S; Khalid F; Weiner HL; Chitnis T; Healy BC; Bakshi R
    J Neurol Sci; 2017 Dec; 383():221-229. PubMed ID: 29146095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.